Age-Related Macular Degeneration (AMD) - Beta Study Telemedicine Assessment

Notal Vision

Status: Completed

Conditions: Age-Related Macular Degeneration

Treatments: Device: FORESEE HOME

Study type: Observational

Funder types: Industry

Identifiers

NCT01083147

ForeseeHome-US3

Details and patient eligibility

About

The purpose of this study is to evaluate the compliance of the Foresee Home device in intermediate AMD patients.

Full description

This is a non-randomized cohort, multi-center study. The eligible subjects will be asked to use the FORESEE HOME device daily and the tests results will be automatically transmitted to the Data Monitor Center for analysis.

Enrollment: 50 patients

Sex: All

Ages: 50+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects who successfully completed participation in ForeseeHome-US2 study
• Patients with ability to comprehend and sign the informed consent/authorization

Exclusion criteria

• Subjects who failed to complete participation in ForeseeHome-US2 study

Trial design

50 participants in 1 patient group

Dry AMD

Description:

subjects diagnosed as intermediate AMD in at least one eye

Treatment:

Device: FORESEE HOME